Fulminating onset type 1 diabetes with positivity for anti-GAD antibody and elevated pancreatic exocrine enzyme concentrations

Internal Medicine

Volumn 42, Issue 6, 2003, Pages 517-520

  Kahara, Toshio ^b   Takamura, Toshinari ^b   Ando, Hitoshi ^b   Sakurai, Masaru ^b   Ota, Tsuguhito ^b   Misaki, Tsuguho ^a   Oba, Sakae ^a   Iguchi, Masaharu ^a   Komori, Kazutoshi ^a   Kobayashi, Ken Ichi ^b  

^a Public Ushitsu Hospital   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Anti GAD antibody; Diabetic ketoacidosis; Fulminant type 1 diabetes; Pancreatic exocrine enzyme

Indexed keywords

AMYLASE; C PEPTIDE; ELASTASE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; INSULIN; INSULIN LISPRO; ISOPHANE INSULIN; TRIACYLGLYCEROL LIPASE;

ABDOMEN; ADULT; AMYLASE BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES CONTROL; DIABETIC KETOACIDOSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTENSIVE CARE; MALE; PANCREAS SECRETION; SYMPTOMATOLOGY; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; URINARY EXCRETION;

EID: 0042672757     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.517     Document Type: Article

References (15)

1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197, 1997.
2. Zimmet PZ, Tuomi T, Mackay IR, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11: 299-303, 1994.
3. Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K. Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of type I diabetes. Diabetes 36: 510-517, 1987.
4. Kobayashi T, Nakanishi K, Okubo M, Murase T, Kosaka K. GAD antibodies seldom disappear in slowly progressive IDDM. Diabetes Care 19: 1031, 1996.
5. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med 342: 301-307, 2000.
6. Baekkeskov S, Aanstoot HJ, Christgau S, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156, 1990.
7. Falorni A, Ackefors M, Carlberg C, et al. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia 39: 1091-1098, 1996.
8. Urakami T, Inami I, Morimoto S, Kubota S, Owada M. Clinical characteristics of non-immune-mediated, idiopathic type 1 (type 1B) diabetes mellitus in Japanese children and adolescents. J Pediatr Endocrinol Metab 15: 283-288, 2002.
9. Sakurai M, Nishimura Y. A case of diabetes mellitus associated with acute pancreatitis. J Japan Diab Soc 45: 415-420, 2002.
10. Shimada A, Morimoto J, Kodama K, et al. T-cell-mediated auto-immunity may be involved in fulminant type 1 diabetes. Diabetes Care 25: 635-636, 2002.
11. Tanaka S, Kobayashi T, Momotsu T. A novel subtype of type 1 diabetes mellitus. N Engl J Med 342: 1835-1837, 2000.
12. Semakula C, Vandewalle CL, Van Schravendijk CF, et al. Abnormal circulating pancreatic enzyme activities in more than twenty-five percent of recent-onset insulin-dependent diabetic patients: association of hyperlipasemia with high-titer islet cell antibodies. Pancreas 12: 321-333, 1996.
13. Shimada A, Oikawa Y, Shigihara T, Senda T, Kodama, K. A case of fulminant type 1 diabetes with strong evidence of autoimmunity. Diabetes Care 25: 1482-1483, 2002.
14. Kawabata Y, Ikegami H, Kawaguchi Y, et al. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 51: 545-551, 2002.
15. Nakanishi K, Kobayashi T, Sugimoto T, Murase T, Itoh T, Kosaka K. Does pan-pancreatic involvement occur in IDDM? Diabetes Care 11: 100-101, 1988.